Hims & Hers Health (NYSE:HIMS) Downgraded by Morgan Stanley to Equal Weight
Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, MarketBeat.com reports. They currently have $60.00 price objective on the stock, up from their prior price objective of $42.00. Other equities analysts have also recently issued research […]
Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, MarketBeat.com reports. They currently have $60.00 price objective on the stock, up from their prior price objective of $42.00. Other equities analysts have also recently issued research […]
